Hydroxymethylnitrofurazone:dimethyl-β-cyclodextrin inclusion complex: A physical-chemistry characterization

Journal of Biological Physics

Volumn 33, Issue 5-6 SPECL.ISSUE, 2007, Pages 445-453

  Grillo, Renato ^a   Silva Melo, Nathalie Ferreira ^a   Moraes, Carolina Morales ^b   Rosa, André Henrique ^a   Frutuoso Roveda, José Arnaldo ^a   Menezes, Carla M S ^a   Ferreira, Elizabeth Igne ^a   Fraceto, Leonardo Fernandes ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Dimethyl cyclodextrin; Hydroxymethylnitrofurazone; Nuclear magnetic resonance; Solubility isotherm

Indexed keywords

EID: 65949102072     PISSN: 00920606     EISSN: 15730689     Source Type: Journal    
DOI: 10.1007/s10867-008-9054-7     Document Type: Article

References (24)

1. Chung, M.C., Guido, R.V.C., Martinelli, T.F., Gonçalves, M.F., Polli, M.C., Botelho, K.C.A., Varanda, E.A., Colli, W., Miranda, M.T.M., Ferreira, E.I.: Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug. Bioorganic Med. Chem. 11, 4779-4783 (2003)
2. Rajewski, R.A., Stella, V.J.: Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85, 1142-1169 (1996)
3. Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325-1357 (1997)
4. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Inst. 4, 117-212 (1965)
5. Loftsson, T., Hreindóttir, D., Másson, M.: Evaluation of cyclodextrins solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005)
6. Loftsson, T., Hreindóttir, D., Másson, M.: The complexation efficiency. J. Incl. Phenom. Macrocycl. Chem. 57, 545-552 (2007)
7. Fraceto, L.F., Spisni, A., Schreier, S., de Paula, E.: Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by H-NMR measurements. Biophys. Chemist. 115, 11-18 (2005)
8. Waldeck, A.R., Kuchel, P.W., Lennon, A.J., Chapman, B.E.: NMR diffusion measurements to characterize membrane transport and solute binding. Progr. Nucl. Magn. Reson. Spectrosc. 30, 39-68 (1997)
9. Fraceto, L.F., Moraes, C.M., Abrami, P., Gonçalves, M.M., Andreo Filho, N., Fernandes, S.A., de Paula, E. Preparação e caracterização Físico-química de complexos de inclusão entre anestésicos locais e hidróxipropil-beta- ciclodextrina. Quim Nova 30, 777-784 (2007)
10. Jesus, M.B., Pinto, L.M.A., Fraceto, L.F., Takahata, Y., Lino, A.C.S., Jaime, C., de Paula, E. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and 1H-Nuclear Magnetic Resonance. J. Pharm. Biomed. Anal 41, 1428-1432 (2006)
11. Wimmer, R., Aachamann, F.L., Larsen, K.L., Petersen, S.B.: NMR diffusion as a novel tool for measuring the association constant between cyclodextrin and guest molecules. Carbohydrate Res. 337, 841-849 (2002)
12. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996)
13. Loukas, Y.L., Vraka, V., Gregoriadis, G.: Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J. Pharm. Biom. Anal. 16, 263-268 (1998)
14. 1H-NMR spectroscopy to determine the enantioselective mechanism of neutral and anionic cyclodextrins in capillary electropho-resis. J. Pharm. Biomed. Anal. 15, 1603-1619 (1997)
15. Johnson Jr., C.S.: Diffusion ordered nuclear magnetic resonance spectroscopy: principles and applications progress in nuclear magnetic resonance. Spectroscopy 34, 203-256 (1999)
16. Rymdém, R., Carlfors, J., Stilbs, P.J.: Substrate binding to cyclodextrins in aqueous solution: a multicomponent self diffusion study. J. Incl. Phenom. Macro. 1, 159-168 (1983)
17. Bakkour, Y., Vermeersch, G., Morcellet, M., Boschin, F., Martel, B., Azaroual, N.: Formation of cyclodextrin inclusion complexes with doxycyclin-hyclate: NMR investigation of their characterization and stability. J. Incl. Phenom. Macrocycl. Chem. 54, 109-114 (2006)
18. Araújo, D.R., Pinto, L.M.A., Braga, A.F.A., de Paula, E.: Local anesthetic formulation for controlled release: therapeutics applications. Rev. Bras. Anestesiol 53, 663-671 (2003)
19. Araújo, D.R., Cereda, C.M.S., Brunetto, G.B., Pinto, L.M.A., Santana, M.H.A., de Paula, E.: Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Can. J. Anesth. 51, 566-572 (2004)
20. Araújo, D.R., Fraceto, L.F., Braga, A.F.A., de Paula, E.: Drug-delivery systems for racemic bupivacaine (S50-R50) and bupivacaine enantiomeric mixture (S75-R25):cyclodextrins complexation effects on sciatic nerve blockade in mice. Rev. Bras. Anestesiol. 55, 316-328 (2005)
21. Moraes, C.M., Abrami, P., de Paula, E., Braga, A.F., Fraceto, L.F.: Study of the interaction between S(-) bupivacaine and 2-hydroxypropyl-beta- cyclodextrin. Int. J. Pharm. 331, 99-106 (2007)
22. Moraes, C.M., Abrami, P., Gonçalves, M.M., Andreo-Filho, N., Fernandes, S.A., de Paula, E., Fraceto, L.F.: Preparação e caracterização físico-química de complexos de inclusão entre anestésicos locais e hidroxipropil-β- ciclodextrina. Quím Nova 30, 777-84 (2007)
23. Moraes, C.M., Abrami, P., de Araújo, D.R., Braga, A.F.A., Issa, M.G., Ferraz, H.G., de Paula, E., Fraceto, L.F.: Characterization of lidocaine: hydroxypropyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 57, 313-316 (2007)
24. Araujo, D.R., Tsuneda, S.S., Cereda, M.S., Carvallho, F.D.G.E., Preté, P.S.C., Fernandes, S.A., Yokaichiya, F., Franco, M.K.K.D., Mazzaro, I., Fraceto, L.F., Braga, A.F.A., de Paula, E.: Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-β-cyclodextrin inclusion complex. Eur. J. Pharm. Sci. 33, 60-71 (2008)